文献速递中医内科中药与中成药合理使用

含三种甘草基原的海藻玉壶汤治疗甲状腺肿的网络药理学与RNA测序研究

Exploring the effect and mechanism of Haizao Yuhu decoction containing three variants of glycyrrhiza on goiter using an integrated strategy of network pharmacology and RNA sequencing.
PubMed 文献 · J Ethnopharmacol · 2023-06-07

该研究以丙硫氧嘧啶(PTU)灌胃14天建立大鼠甲状腺肿模型,分别给予含乌拉尔甘草、光果甘草或胀果甘草的海藻玉壶汤治疗4周。三种汤剂均减轻甲状腺绝对/相对重量、改善病理结构与甲状腺功能,其中含乌拉尔甘草者效果更优。网络药理学联合RNA测序提示其机制与抑制PI3K-Akt通路、进而抑制血管生成和细胞增殖有关。

要点

  • 含三种甘草基原的海藻玉壶汤均可改善PTU诱导的大鼠甲状腺肿。
  • 含乌拉尔甘草的海藻玉壶汤在改善甲状腺肿方面效果更优。
  • 机制涉及抑制PI3K-Akt通路,减少血管生成与细胞增殖。

核心结论

  • 三种含不同甘草基原的海藻玉壶汤均对甲状腺肿有明确疗效,以含乌拉尔甘草者效果更优。
  • 三种汤剂通过抑制PI3K-Akt信号通路,抑制甲状腺肿组织的血管生成和细胞增殖。

研究设计与样本

  • 采用PTU灌胃14天建立大鼠甲状腺肿模型,随后以含三种不同甘草基原的海藻玉壶汤治疗4周。
  • 通过一般观察、甲状腺绝对/相对重量、甲状腺功能指标和甲状腺组织病理评估药效。
  • 利用网络药理学联合RNA测序探索机制,并用RT-qPCR、WB和IF验证关键靶点。

主要发现

  • 三种海藻玉壶汤均降低甲状腺绝对/相对重量,改善甲状腺病理结构、甲状腺功能及一般状况。
  • 整体上含乌拉尔甘草的海藻玉壶汤效果更好。
  • 网络药理学与RNA-seq共同提示甲状腺肿发病机制及海藻玉壶汤作用机制均与PI3K-Akt通路相关。
  • PTU诱导的甲状腺肿大鼠中PI3K-Akt通路过度激活,三种海藻玉壶汤均可抑制该通路。

关键数值与推荐

  • 甲状腺功能指标包括三碘甲状腺原氨酸、甲状腺素、游离三碘甲状腺原氨酸、游离甲状腺素和促甲状腺激素水平。
  • 验证的关键靶点包括VEGFA、VEGFR2、PIK3R1及其编码蛋白PI3K(p85)、AKT1、磷酸化AKT和cyclin D1。

临床怎么用

  • 临床选用海藻玉壶汤治疗甲状腺肿时,可优先考虑含乌拉尔甘草的版本。
  • 其作用机制可能与抑制PI3K-Akt通路有关,可作为进一步临床与基础研究的参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Haizao Yuhu decoction (HYD) is a classic Chinese herbal formula described in the surgical monographs of the Ming Dynasty "Waikezhengzong." It has been widely used to treat goiter for approximately 500 years and found to be particularly effective. HYD contains glycyrrhiza and sargassum. This pair of herbs belongs to "18 incompatible medicaments" of traditional Chinese medicine theory. Although these two herbs are opposite, our preliminary study proved that they have superior effect when added into HYD at 2 times the dose of Chinese Pharmacopoeia. However, the species of glycyrrhiza in HYD that are the most effective have not been recorded in ancient Chinese medical texts. According to the Chinese Pharmacopoeia, glycyrrhiza is divided into the following three species: Glycyrrhiza uralensis Fish., G. glabra L., and G. inflata Bat. The effect of HYD containing different species of glycyrrhiza and their mechanisms remain to be further explored. AIM OF THE STUDY: To investigate the effect of HYD containing three species of glycyrrhiza on goiter, and to elucidate the molecular mechanism using network pharmacology combined with RNA sequencing (RNA-seq). MATERIALS AND METHODS: A rat model of goiter was established by 14 days of intragastric gavage of propylthiouracil (PTU), and the rats were treated for 4 weeks with HYD containing three different species of glycyrrhiza. The body weight and rectal temperature of rats were tested weekly. At the end of the experiment, the serum and thyroid tissues of rats were collected. The effect of the three HYDs was assessed based on general observations (including body weight, rectal temperature, and living status of rats), absolute/relative thyroid weight, thyroid function (including triiodothyronine, thyroxine, free triiodothyronine, free thyroxine, and thyroid-stimulating hormone levels), and thyroid tissue pathology. Next, we explored their pharmacological mechanisms using network pharmacology combined with RNA-seq and validated key targets using real-time quantitative reverse-transcription polymerase chain reaction (RT-qPCR), western blotting (WB), and immunofluorescence (IF) assays. RESULTS: The three HYDs reduced the absolute/relative weights of thyroid tissues and improved the pathological structure, thyroid function, and general findings of rats with goiter. Overall, the effect of HYD-G. uralensis Fish. (HYD-U) was better. Results from network pharmacology and RNA-seq jointly suggested that both the pathogenesis of goiter and the mechanism of action of HYD for goiter were related to the phosphatidylinositol 3-kinase-protein kinase B (PI3K-Akt) pathway. We validated the key targets in the pathway, namely, vascular endothelial growth factor (VEGF) A, VEGF receptor 2, phosphoinositide-3-kinase regulatory subunit 1 (PIK3R1) and its encoded protein PI3K (p85), AKT serine/threonine kinase 1 (AKT1), phospho-AKT and cyclin D1 using RT-qPCR, WB, and IF assays. The PI3K-Akt pathway was hyperactivated in rats with PTU-induced goiter, whereas the three HYDs could inhibit the pathway. CONCLUSION: This study confirmed the definite effect of the three HYDs in the treatment of goiter, and HYD-U was found to be more effective. The three HYDs inhibited angiogenesis and cell proliferation in goiter tissue by inhibiting the PI3K-Akt signaling pathway.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Li M, Xiu L, Liao W, et al. Exploring the effect and mechanism of Haizao Yuhu decoction containing three variants of glycyrrhiza on goiter using an integrated strategy of network pharmacology and RNA sequencing. J Ethnopharmacol. 2023. PMID: 37295576. doi:10.1016/j.jep.2023.116750

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。